tebnow← All categories
Category

Health Tech

1243 articles indexed

Trump Administration Cuts ACA Subsidies for 189,000 Due to Duplicate and Deceased Enrollees

In a significant move, the Trump administration has eliminated health subsidies for 189,000 individuals enrolled in the Affordable Care Act (ACA) exchanges. This decision follows the identification of duplicate beneficiaries on Medicaid and Medicare, as well as deceased enrollees. The Centers for Medicare & Medicaid Services (CMS) announced that this action is expected to save approximately $738 million in improper payments for the current year. CMS officials indicated that an additional 3,500 subsidies will be removed by the end of the month as part of ongoing efforts to combat fraud, waste, and abuse in federal programs. CMS Administrator Mehmet Oz emphasized that no individuals will lose their health insurance coverage as a result of this crackdown. The administration's focus is on ensuring that subsidies are not being fraudulently claimed. Last year, similar actions led to the revocation of subsidies for about 551,000 enrollees found to be receiving duplicate benefits from Medicaid. Additionally, over 760,000 individuals had their ACA coverage terminated due to unauthorized enrollment. The CMS is mandated to conduct regular data analyses to identify overlapping coverage, which is crucial for maintaining the integrity of the ACA exchanges. This year, overlapping Medicaid coverage accounted for approximately 120,000 cases, while 58,000 involved duplicate Medicare coverage and 11,000 pertained to deceased enrollees. Enrollees identified as duplicates are given a 30-day window to respond, and estates of deceased individuals are also contacted for verification. This latest initiative comes amid broader changes in the ACA landscape, particularly after the expiration of enhanced financial subsidies last year, which led to a significant increase in average premiums. A recent poll indicated that about 10% of enrollees dropped their marketplace coverage due to these rising costs, resulting in a rise in the uninsured population. The ongoing scrutiny of the ACA exchanges reflects the administration's commitment to ensuring that federal funds are allocated appropriately and that beneficiaries meet eligibility requirements.

Healthcare Dive/8h ago

Affordable Care Act / health subsidies / fraud prevention / Medicaid / Medicare

Centene Launches Gold Card Program to Streamline Prior Authorization Process

Centene Corporation has announced the launch of its National Performance-Based Gold Card Program, set to begin next month. This initiative aims to reform the prior authorization process by exempting high-performing providers from routine authorization requirements for specific medical services, procedures, or prescriptions. Over 160,000 providers across the United States will be eligible for this program based on their historical performance, documentation quality, and compliance with medical policies and regulations. The initial phase of the program will focus on certain outpatient services, with plans for future expansion to include a broader range of services and providers. While qualifying providers will still need to submit a pre-notification before delivering care, they will no longer have to wait for prior approval from Centene, thereby facilitating quicker patient care. This move is part of a larger trend in the healthcare industry, where gold card programs are gaining traction as a means to alleviate administrative burdens and reduce delays in patient treatment. Historically, insurers have been hesitant to adopt such programs due to concerns about potential over-utilization of services. However, legislative pressure from nearly a dozen states, along with federal scrutiny, has prompted insurers to reconsider their stance. The Trump administration previously secured commitments from major insurers to reduce prior authorization processes, resulting in an 11% reduction in authorizations earlier this year. Other insurers, such as Humana and UnitedHealthcare, have also initiated similar programs, reflecting a growing recognition of the need for reform in prior authorization practices. Despite these advancements, many healthcare providers and patients continue to express dissatisfaction with the prior authorization system, arguing that reforms have not significantly reduced their workloads or improved patient access to necessary care. As the healthcare landscape evolves, the success of Centene's gold card program and similar initiatives will be closely monitored by stakeholders across the industry.

Healthcare Dive · 13h ago

MultiCare and Samaritan Health Services Set to Merge on November 1

MultiCare and Samaritan Health Services have announced their merger, set to take effect on November 1, following the approval from state regulators. This strategic partnership will allow MultiCare, which operates 13 hospitals in Washington, to affiliate with Samaritan's network of five hospitals in Oregon. As part of the agreement, MultiCare will invest $700 million over the next decade into Samaritan, enhancing its capabilities and resources to better serve the community. The merger is significant as it aims to address the increasing healthcare demands in the region and provide Samaritan with the necessary tools and technology to improve its services. Marty Cahill, president and CEO of Samaritan, emphasized that this milestone will enable the partnership to effectively utilize their combined resources for the benefit of the communities they serve. The collaboration is also seen as a strategic move to help Samaritan navigate potential cuts to healthcare programs. The merger process began in late 2025, with both organizations expressing their commitment to enhancing healthcare delivery. The Oregon Health Authority approved the merger in August, with the final regulatory approval concerning Samaritan's health plans received recently. With all public agencies either approving or planning to approve the merger, the integration of these two health systems is poised to expand MultiCare's footprint into Oregon and strengthen healthcare services in the region.

Healthcare Dive · 13h ago

CVS Agrees to $315M Settlement Over Unnecessary Opioid Prescriptions

CVS Pharmacy has reached a $315 million settlement with the U.S. government to resolve allegations of dispensing unnecessary opioid prescriptions, as announced by the Department of Justice (DOJ). This settlement addresses claims that CVS violated Medicare rules by seeking reimbursement for prescriptions deemed medically unnecessary. Although CVS did not admit to any wrongdoing, the company expressed a desire to move forward from the litigation. The opioid epidemic has had devastating effects, with nearly 80,000 deaths reported in 2023 alone, marking a significant increase in mortality compared to previous years. The DOJ's actions are part of a broader effort to hold corporations accountable for their roles in the crisis, which has seen drug manufacturers, distributors, and retailers pay billions in settlements. CVS has previously settled lawsuits related to opioid prescribing for a total of $5 billion. The recent settlement resolves a lawsuit initiated by the Biden administration in 2024, which accused CVS of knowingly filling prescriptions without legitimate medical purposes and dispensing opioids in excessive quantities. The DOJ highlighted that CVS's practices prioritized profits over patient safety, including performance metrics that discouraged pharmacists from reporting problematic prescribers. As part of the settlement, CVS is mandated to establish a hotline for reporting illegal drug dispensing and to monitor pharmacy dispensing patterns, which prosecutors believe will enhance protections for patients and federal healthcare programs. This settlement is viewed as a significant step in the DOJ's ongoing efforts to combat the opioid crisis and ensure accountability in the pharmaceutical industry.

Healthcare Dive · 13h ago

UnitedHealth Reports Strong Q3 Profit Growth, Adjusts 2026 Earnings Guidance Amid Medicare Advantage Strategy

UnitedHealth Group has reported a significant profit increase of 75% year-over-year for the third quarter of 2023, reaching $4.1 billion on revenues of $112.7 billion, despite a slight revenue decline of 0.4%. This growth comes as the company continues to refine its Medicare Advantage (MA) strategy, focusing on profitability by reducing membership and enhancing margins. The insurer's medical loss ratio improved to 88.4%, indicating better retention of premium dollars for administrative and profit purposes. The company has raised its earnings guidance for 2026 for the third time this year, reflecting confidence in its operational adjustments and market positioning. UnitedHealth's payer arm, UnitedHealthcare, and its care delivery unit, Optum Health, both exceeded Wall Street expectations, with Optum reporting an operating income of $735 million, a substantial increase from the previous year. However, the company anticipates losing over 1 million MA enrollees by 2026 due to premium hikes and benefit cuts, which are expected to enhance profitability in the long run. Despite the positive financial outlook, UnitedHealth faces challenges, including a decline in star ratings for its MA plans, which could impact revenue in 2028. The percentage of members in plans with at least 4 stars dropped from 81% to 68%. Additionally, the Medicaid division is grappling with funding gaps and high utilization rates, projecting a -1% margin for the year. The company is also dealing with increased costs from out-of-network disputes under the No Surprises Act, which have significantly affected its medical spending. Looking ahead, UnitedHealth remains focused on strategic adjustments to enhance profitability and navigate the evolving healthcare landscape.

Healthcare Dive · 1d ago

Hospitals Challenge HHS Over Controversial 340B Rebate Pilot Program

A coalition of hospitals, including the American Hospital Association and several safety-net facilities, has filed a lawsuit against the Department of Health and Human Services (HHS) regarding its new pilot program that aims to convert 340B drug discounts into a rebate system. This legal action marks the second time hospitals have contested HHS's approach, which they argue jeopardizes their financial stability by shifting from upfront discounts to post-purchase rebates. The lawsuit highlights concerns that the Health Resources and Services Administration (HRSA) has underestimated the administrative burden and costs associated with the rebate program, which is set to launch in January. The 340B program, established in 1992, allows hospitals that serve a significant number of low-income and uninsured patients to purchase outpatient drugs at substantial discounts, typically between 25% and 50% off the list price. Hospitals contend that this program is vital for their operations, enabling them to provide care to vulnerable populations. However, pharmaceutical companies have criticized the program, alleging that hospitals exploit it for profit, with 340B drug purchases reaching $100 billion last year, a 23% increase from the previous year. The Biden administration has defended the upfront discount model against drugmakers' criticisms, while the Trump administration previously attempted to implement rebate systems, which faced legal challenges. The current lawsuit argues that HRSA's cost analysis of the rebate program is fundamentally flawed, estimating annual costs at $537 million, while hospitals assert that true costs could exceed $1 billion when accounting for startup, IT, training, and other expenses. This financial strain comes at a time when hospitals are already facing challenges from Medicaid cuts and rising operational costs due to inflation. Hospital leaders warn that the rebate program could have dire consequences for patient care, particularly in states like Maine, where hospitals operate with minimal cash reserves. The lawsuit emphasizes the need for the government to consider the implications of such significant changes on patient access to care and the sustainability of safety-net providers. As the legal battle unfolds, the future of the 340B program and its impact on healthcare delivery remains uncertain.

Healthcare Dive · 2d ago

Proposed Bill Aims to Reform No Surprises Act Arbitration Process Amid Rising Healthcare Costs

Representative Frank Pallone (D-N.J.) has introduced a new bill, the 'Lower Premiums, Faster Payments Act,' which seeks to eliminate the arbitration process established by the No Surprises Act for resolving out-of-network billing disputes between healthcare providers and payers. This legislative move comes as concerns grow regarding the arbitration process's contribution to escalating healthcare costs, with estimates suggesting it has added over $22 billion to healthcare expenditures since its implementation in 2022. The bill proposes to end arbitration entirely after 2027, mandating that plans pay providers flat out-of-network rates based on in-network payment comparisons. The No Surprises Act was designed to protect patients from unexpected medical bills, particularly in cases where they receive out-of-network care at in-network facilities. While the law has largely succeeded in shielding patients from surprise bills, the arbitration process has faced criticism for being contentious and leading to inflated payments for providers. Research indicates that providers often win disputes and receive payments significantly higher than what insurers would typically pay in-network, with some cases resulting in reimbursements over 80 times higher than Medicare rates. Lawmakers, including Pallone, have expressed concerns about the role of private equity firms in exploiting the dispute resolution process, with a significant portion of disputes being resolved by a few private-equity backed organizations. The proposed legislation aims to address these issues by establishing a more standardized payment system that adjusts annually based on the Consumer Price Index, thereby aligning provider reimbursements with inflation. However, the bill has faced pushback from provider groups, who argue that it may further empower insurers at the expense of fair compensation for healthcare services. As the bill moves forward, it is expected to spark significant debate among stakeholders in the healthcare industry, including providers, insurers, and lawmakers, as they navigate the complexities of healthcare financing and patient protection. Pallone, a key figure in the original No Surprises Act, continues to advocate for reforms that address the shortcomings of the current arbitration system while ensuring that patient care remains a priority.

Healthcare Dive · 2d ago

Rethinking Market Strategy: Integrating Service Area, Workforce, and Care Maps for Health Plans

Health plans often rely on service-area maps to define their operational boundaries, but this approach can overlook critical market dynamics. A service-area map indicates where a health plan is licensed and where it can enroll members, yet it fails to capture where employees of local employers actually reside and seek care. This disconnect can lead to misjudged market opportunities and ultimately affect member retention and acquisition costs. To accurately assess market potential, health plans should consider three interconnected maps: the service-area map, the workforce map, and the care map. The service-area map outlines the licensed operational footprint, while the workforce map reveals where employees live and commute from, which can span multiple counties. The care map identifies where members and their families seek medical services. The intersection of these three maps provides a clearer picture of the real market and potential opportunities, while the gaps highlight areas of network inadequacy or strategic misalignment. The implications of misjudging market boundaries are significant, especially given that employer-sponsored coverage is the largest source of health insurance in the U.S., affecting approximately 154 million individuals under 65. With family coverage costs averaging nearly $27,000 annually, health plans must strategically allocate their resources to avoid costly mistakes. A misaligned market strategy can lead to increased acquisition costs and decreased member retention, particularly for regional and mid-market plans that cannot absorb losses as easily as national plans. Before entering a new market or pursuing an employer account, health plans should critically evaluate their strategies by asking key questions about market behavior, workforce demographics, network reach, and competitive landscape. By integrating insights from all three maps, health plans can make informed decisions about growth opportunities and network enhancements, ultimately aligning their operational strategies with actual market needs. Data Axle for Healthcare offers tools to help health plans visualize these dynamics and prioritize their market strategies effectively.

Healthcare Dive · 2d ago

Navigating Careers in Digital Health and Healthcare AI: Insights for Professionals

As the fields of digital health and healthcare AI continue to expand, professionals from various backgrounds are seeking guidance on how to transition into these burgeoning sectors. This article provides insights into the necessary skills and knowledge required for individuals looking to enter or shift within these domains. Researchers are encouraged to explore promising topics such as diabetes management through wearable technology and the impact of ECG smartwatches on hospital admissions, emphasizing the importance of identifying niches and addressing significant questions. For those with a medical background, understanding the intersection of technology and clinical needs is crucial. Medical professionals can enhance their contributions by familiarizing themselves with technological challenges and pursuing relevant educational resources. This approach ensures that innovations in digital health are aligned with real healthcare requirements, ultimately leading to patient-centered solutions. Tech professionals are advised to focus on understanding medical and patient needs to create impactful healthcare solutions. Engaging in patient-centered design and incorporating feedback from medical experts can bridge the gap between technological advancements and practical healthcare applications. Individuals transitioning from traditional med-tech to digital health must adapt to a broader user base and prioritize user-friendly designs. This shift also involves embracing a more open approach to health data, empowering patients in their health management while addressing privacy and security challenges. Overall, the article serves as a comprehensive guide for professionals aiming to navigate the evolving landscape of digital health and healthcare AI.

The Medical Futurist · 5d ago

Hospitals Accelerate Outpatient Care Shift Amid Rebounding Margins and Patient Demand

A recent analysis by Strata Decision Technology reveals a significant trend in healthcare as hospitals increasingly transition care to outpatient settings. This shift is driven by rising patient demand and payer pressures, allowing hospitals to manage costs more effectively while addressing the needs of lower-acuity patients. The data, which encompasses over 2,000 hospitals and 149,000 providers, indicates that hospitals are now treating sicker patients in inpatient wards, particularly in service lines such as breast health, where an uptick in cancer testing has led to more complex cases being admitted. The analysis highlights that outpatient procedures, particularly in areas like gynecology, are becoming more prevalent due to advancements in minimally invasive surgical techniques. These innovations not only reduce costs but also align with patient preferences for more accessible and affordable care options. Vizient projects a 20% increase in outpatient volumes over the next decade, contrasting with a modest 7% rise in inpatient discharges, suggesting a long-term trend towards outpatient care. Financially, hospitals are beginning to see improvements in their operating margins, which reached 0.7% by the end of June, despite ongoing challenges with inflated drug and supply costs. This recovery is partly attributed to the Centers for Medicare & Medicaid Services (CMS) phasing out the inpatient-only list, which restricts certain procedures to inpatient settings. With over 280 procedures removed from this list this year and plans for complete elimination by 2028, the landscape for outpatient care is set to evolve significantly. Payers are also adapting to this shift, with some, like Elevance Health, implementing new billing policies that favor outpatient services. As the healthcare system continues to navigate these changes, the focus on outpatient care is expected to grow, reshaping the delivery of medical services and potentially leading to cost savings for both providers and patients.

Healthcare Dive · 6d ago

Medicare Increases Hospital Readmission Penalties, Affecting 80% of Facilities in 2027

The Centers for Medicare & Medicaid Services (CMS) has reported that 80% of hospitals will face reduced Medicare payments due to the Hospital Readmissions Reduction Program (HRRP) for the fiscal year 2027. This marks an increase from 78% in the previous year, with 2,334 hospitals penalized compared to 2,304 in 2026. The penalties, which took effect on October 1, are based on readmission data that now includes Medicare Advantage beneficiaries, reflecting a broader scope of patient outcomes. The HRRP, established under the Affordable Care Act, aims to incentivize hospitals to reduce avoidable readmissions for conditions such as heart attacks and pneumonia. The penalties are calculated based on Medicare data from the summer of 2023 to the summer of 2025, with potential reductions in payments reaching up to 3%. However, most affected hospitals will see penalties of less than 1%. Notably, only 10 hospitals will incur the maximum penalty, a decrease from 15 in the previous year, while 578 hospitals, or about 20%, will avoid penalties altogether, a decline from 22% in 2026. This trend indicates a second consecutive year of worsening performance among U.S. hospitals regarding readmission rates. The HRRP initially led to significant reductions in readmissions since its implementation in 2012, prompting hospitals to enhance discharge planning and patient education. While the program has saved Medicare billions and has not adversely affected patient mortality rates, it has faced criticism for disproportionately impacting safety-net hospitals that serve higher-risk populations. Stakeholders continue to express concerns about the fairness of the penalties, and some researchers argue that the observed reductions in readmissions may stem from changes in tracking practices rather than genuine improvements in care quality.

Healthcare Dive · 6d ago

Texas AG Investigates UnitedHealth for Alleged Care Denials and Deceptive Practices

Texas Attorney General Ken Paxton has initiated an investigation into UnitedHealth, citing alarming reports of care denials that may violate the Deceptive Trade Practices Act and other state laws. The investigation focuses on claims that UnitedHealth has engaged in deceptive practices, including incentivizing nursing homes to keep patients out of hospitals, thereby compromising necessary medical care for Texans. Paxton has issued civil investigative demands to gather evidence regarding these allegations. This investigation adds to UnitedHealth's ongoing regulatory challenges, which have included scrutiny from the Department of Justice and various federal agencies concerning its Medicare billing practices and nursing home care denials. The company has faced significant criticism and has attempted to improve its public image through corporate restructuring and pledges for greater transparency. Paxton's actions reflect a growing concern among Texas voters regarding healthcare corporations prioritizing profits over patient care. He has previously launched similar investigations into other insurers, including Blue Cross and Blue Shield of Texas. As the political landscape heats up with Paxton's Senate campaign, the outcome of this investigation could have significant implications for both UnitedHealth and the broader healthcare industry in Texas.

Healthcare Dive · Oct 7

EHealth Implements AI Voice Agent to Enhance Medicare Enrollment Experience

EHealth, Inc., a private health insurance agency, has successfully integrated Regal's AI voice agent, Alice, into its operations to streamline the Medicare enrollment process. During the critical two-month open enrollment period, which sees approximately half a million calls, the AI agent has significantly reduced wait times for seniors seeking assistance. Previously, customers faced wait times of up to six hours to speak with a human agent, but Alice now answers calls immediately, achieving a 77% satisfaction rating and a 27% higher purchase rate compared to traditional methods. The deployment of Alice began with a pilot program in February 2025, which focused on after-hours calls. Insights gained from this pilot informed the development of a full-time AI agent capable of handling complex and sensitive conversations. Unlike legacy systems that require explicit programming, Alice utilizes a large language model (LLM) to understand nuanced language, allowing it to respond empathetically to callers, including those dealing with personal loss. Compliance with healthcare regulations posed challenges, particularly regarding lengthy privacy statements that often interrupted the flow of conversation. EHealth and Regal developed a solution that allowed the AI to manage these interruptions effectively, ensuring a seamless transition back to human agents for personalized assistance. The implementation process involved extensive testing and collaboration across departments to address stakeholder concerns about AI reliability and compliance. As EHealth continues to refine Alice, the agency aims to enhance the customer experience further while navigating the complexities of Medicare enrollment. The success of this initiative highlights the potential of AI in improving healthcare service delivery, particularly for vulnerable populations like seniors.

Healthcare Dive · Oct 7

FTC Warns Hospitals on Price Transparency Compliance Amid Regulatory Crackdown

The Federal Trade Commission (FTC) has issued warning letters to approximately two dozen hospital systems regarding their compliance with federal consumer protection laws related to price transparency. This action, taken by FTC Chairman Andrew Ferguson, emphasizes the necessity for hospitals to disclose accurate and timely pricing information for their services. The letters serve as a reminder that failure to comply could lead to scrutiny from both the FTC and the Department of Health and Human Services (HHS). Price transparency has been a significant focus for health officials, particularly during the Trump administration, which has sought to enhance consumer access to healthcare pricing. The Centers for Medicare & Medicaid Services (CMS) implemented a rule in late 2019 requiring hospitals to publicly post their standard charges, including negotiated rates with insurers. Despite these regulations, compliance has been slow, with over half of hospitals reportedly not fully adhering to the CMS price transparency rule as of September 2026. The FTC's involvement marks a new phase in the enforcement of price transparency, as hospitals could face violations for not posting complete pricing information, which could mislead consumers about the total cost of care. The recent letters from the FTC coincide with new regulations from the HHS and other departments aimed at improving price transparency among insurers, indicating a broader governmental push to ensure that patients have access to clear and comprehensive pricing information. As the healthcare landscape continues to evolve, the implications of these regulatory actions could lead to increased accountability among hospitals and potentially lower medical costs for consumers. The FTC's warnings highlight the ongoing challenges in achieving full compliance with price transparency regulations and the importance of clear communication in healthcare pricing.

Healthcare Dive · Oct 6

Agentic AI: Transforming Health Insurance Operations for Enhanced Member Experience

A recent study by JD Power reveals that only 30% of commercial health plan members view their insurers as trusted partners in health and wellness. In response, health insurers are significantly investing in digital tools, including chatbots and self-service portals. However, the effectiveness of these investments is hindered by fragmented automation across various departments, leading to inefficiencies and increased friction in member services and prior authorization processes. A survey by the American Medical Association highlights that prior authorization consumes an average of 13 hours of physician and staff time weekly, with 95% of physicians reporting delays in access to necessary care. Agentic AI presents a solution by enabling a more integrated approach to health insurance operations. Unlike traditional automation that executes discrete tasks, agentic AI can pull information from multiple sources, identify gaps, and facilitate follow-ups. This orchestration can streamline member services by providing a comprehensive view of a member's eligibility and claims history before a call connects, thereby reducing wait times and expediting complex cases to human representatives with full context. Moreover, agentic AI can enhance the prior authorization process by checking documentation against payer criteria and initiating requests through connected workflows, minimizing paperwork and allowing physicians to focus on medical necessity decisions. The American Hospital Association reports that hospitals spent approximately $43 billion in 2025 pursuing payments from insurers, emphasizing the need for improved documentation and compliance processes. Highmark Health is leading the way by collaborating with Abridge to develop a system that compares authorization requirements with real-time patient visit information, aiming to reduce denials due to missing documentation. As the industry moves towards adopting agentic AI, it is crucial to ensure responsible deployment, clear escalation paths for exceptions, and routine monitoring for bias, while maintaining human oversight for clinical and coverage judgments.

Healthcare Dive · Oct 5

Improving Patient Access: The Importance of Workflow Over Staffing Solutions

Patient access issues in healthcare practices are often misdiagnosed as staffing shortages, but the root cause frequently lies in inefficient workflows. When patients face challenges in reaching a practice, scheduling appointments, or receiving timely responses, the instinctive solution is to hire more staff. However, simply adding personnel to a fragmented process can exacerbate existing inefficiencies, leading to longer hold times, unanswered calls, and scheduling delays. Understanding that patient access begins well before the appointment is crucial; it encompasses every interaction a patient has with the practice, from initial inquiries to appointment confirmations. Healthcare practices must recognize that increasing capacity does not necessarily resolve bottlenecks. For instance, a scheduling request that involves multiple manual steps can create delays, and hiring additional staff may only provide a temporary fix. Practices should analyze the underlying causes of demand for staff intervention, such as unresolved patient inquiries or inefficient information retrieval processes. By shifting the focus from merely handling more work to understanding the reasons behind the workload, practices can identify and address the true sources of access problems. Automation can play a significant role in enhancing patient access, but it must be applied judiciously. The goal should not be to automate every interaction but to streamline routine processes that can be clearly defined. By reducing administrative friction, practices can free up staff to focus on more complex patient interactions that require human empathy and judgment. Effective automation should follow a thorough design of workflows to ensure that it alleviates unnecessary tasks rather than compounding inefficiencies. Finally, practices need to measure outcomes rather than just activities to truly improve patient access. Traditional metrics like call volume and appointment availability provide limited insights. Instead, practices should evaluate the entire patient journey, assessing how many steps it takes to schedule an appointment and how often patients need to follow up. By focusing on resolution metrics, practices can uncover hidden inefficiencies and enhance the overall patient experience, ultimately leading to a more effective operating model for patient access.

Healthcare Dive · Oct 5

FDA Sets 2027 Priorities for AI and Surgical Robot Guidance Finalization

The FDA has announced its guidance priorities for the fiscal year 2027, focusing on artificial intelligence (AI) and robotically assisted surgical devices. Among the top priorities is the finalization of guidance documents related to marketing submissions and lifecycle management for AI-enabled devices, as well as drafting recommendations for generative AI applications in mental health treatment. This initiative is crucial as it aims to establish a regulatory framework that ensures the safety and efficacy of these emerging technologies in healthcare. The agency's commitment to finalizing guidance on robotically assisted surgical devices is also noteworthy. The draft guidance, recently published, outlines recommendations for nonclinical testing, clinical data requirements, and labeling for these devices. The FDA is accepting feedback on this draft until November 24, 2026, with plans to finalize it within a year. This move is expected to enhance the regulatory clarity for manufacturers and improve patient safety in surgical procedures. In addition to AI and surgical robots, the FDA has identified other priorities, including guidance on air-purifying respirators, menstrual product testing, and quality management systems. Notably, the agency is also working on finalizing guidance for pulse oximeters, addressing concerns regarding the impact of skin pigmentation on measurement accuracy. This guidance is particularly relevant given the increasing reliance on pulse oximetry in clinical settings. The FDA's proactive approach in setting these priorities reflects its ongoing efforts to adapt to technological advancements in healthcare. By prioritizing these areas, the FDA aims to foster innovation while ensuring that new medical technologies meet rigorous safety and effectiveness standards. Stakeholders are encouraged to provide feedback on these priorities, which will shape the regulatory landscape for the coming year.

Healthcare Dive · Oct 2

Democratic Governors Seek Delay in Medicaid Work Requirements Implementation Amid Compliance Challenges

Five Democratic governors have formally requested the U.S. Department of Health and Human Services (HHS) to postpone the January 1, 2027 deadline for states to implement new Medicaid work requirements. The governors of Oregon, California, Maine, New Mexico, and Virginia argue that recent guidance from the Centers for Medicare & Medicaid Services (CMS) has created unexpected administrative hurdles that could jeopardize Medicaid access for millions. They express concern that the stringent requirements, part of a national mandate passed in a Republican reconciliation bill, could lead to significant coverage losses among eligible beneficiaries. The work requirements, which tie Medicaid eligibility to work, education, or volunteer hours, affect approximately 21 million individuals who gained coverage through the Affordable Care Act expansion. The governors contend that the timeline for compliance is unrealistic, given the complexity of the changes introduced by the CMS, including stricter rules for exemptions and verification processes. They emphasize that these adjustments fundamentally alter the implementation landscape for states, which have only 18 months to adapt their systems and outreach efforts with limited federal support. Nebraska has already begun enforcing work requirements, revealing early data that indicates significant coverage losses due to administrative challenges. Nearly 560 new applicants have been denied Medicaid coverage, with 84% of those denials attributed to failure in providing necessary compliance information. Additionally, among those renewing their coverage, 92% of individuals who were removed from the program did not respond to verification requests. The governors' letter highlights the urgent need for HHS to collaborate with states to establish a more feasible implementation timeline to protect vulnerable populations from losing their healthcare coverage.

Healthcare Dive · Oct 2

Elevance Health Introduces New Billing Policies to Regulate Off-Campus Hospital Payments

Elevance Health has announced new billing policies aimed at regulating payments for services provided at off-campus hospital outpatient departments. Effective throughout 2026 and 2027, these policies will require hospitals to specify the exact location of care, allowing Elevance to cross-check this data and apply lower reimbursement rates for off-campus services and lab tests. This initiative is designed to enhance transparency and address the issue of inflated costs associated with higher hospital rates for care delivered outside hospital campuses. The American Hospital Association (AHA) has voiced strong opposition to Elevance's policies, arguing that the reimbursement cuts could jeopardize access to care at outpatient departments. AHA representatives contend that these unilateral cuts may benefit Elevance financially while compromising patient access to essential services. Elevance serves approximately 45 million members across its commercial, Medicare Advantage, and Medicaid plans, and aims to implement site-of-care payment principles that reflect the actual location of care delivery. Research indicates that hospital-owned outpatient departments often charge significantly higher prices—up to 13.5 times more than standalone physician offices—due to facility fees that cover overhead costs. This trend has been exacerbated by hospital consolidation, where independent practices are acquired and reclassified as outpatient departments, allowing hospitals to maintain higher billing rates. While insurers and patient advocates argue that care should not be more expensive simply because a hospital owns a clinic, hospital groups maintain that the higher rates are justified by the unique costs associated with hospital operations. Elevance's policy changes align with broader regulatory efforts to establish site-neutral payment models. Recent legislative measures require hospitals to adopt separate billing identifiers for off-campus outpatient departments by 2028, and the Centers for Medicare & Medicaid Services (CMS) is also moving towards equalizing payment rates for imaging services across different care settings. As these changes unfold, the healthcare landscape may see significant shifts in how outpatient services are billed and reimbursed, impacting both providers and patients alike.

Healthcare Dive · Sep 30

Medicare Advantage Plans Face Significant Cuts for 2027 Enrollment Period

The upcoming 2027 Medicare Advantage (MA) enrollment period is set to present challenges for seniors, as major insurers have significantly reduced the number of plans available. According to a recent analysis of government data by Healthcare Dive, the total number of MA plans is expected to decrease slightly from 5,553 in 2026 to 5,532 in 2027. This reduction comes as insurers aim to recover from high medical spending by cutting back on offerings and increasing cost-sharing for remaining plans. As a result, many beneficiaries may find their current plans eliminated or face higher out-of-pocket costs. The changes are particularly concerning given that nearly 3 million seniors had to switch plans in 2026 due to similar cutbacks. Insurers like UnitedHealthcare and Humana are among those making the most significant reductions, with UnitedHealthcare cutting approximately 690 plans and Humana eliminating around 2,400. While some smaller insurers are expanding their offerings, the overall trend indicates a contraction in the number of plans and counties served by major insurers. Despite these cuts, the Centers for Medicare & Medicaid Services (CMS) has attempted to reassure beneficiaries by stating that over 99% will still have access to at least one MA plan. However, projections suggest that MA enrollment could drop to 34 million, marking a decline of about 2 million beneficiaries. This decline could result in MA plans accounting for less than half of the total Medicare population for the first time since 2023. The CMS has highlighted that while premiums are expected to decrease, many seniors may face increased cost-sharing, leading to higher overall healthcare expenses. As the enrollment period approaches, the landscape for Medicare Advantage remains uncertain, with potential disruptions for beneficiaries as they navigate fewer options and higher costs. Insurers are likely to continue prioritizing margin improvement over membership growth, which could further complicate the choices available to seniors in the coming year.

Healthcare Dive · Sep 29

Oura Postpones IPO Amid Market Uncertainty, Aims for Future Growth

Oura, the maker of the popular smart ring, has announced a delay in its planned initial public offering (IPO) due to prevailing market uncertainties. Initially, the company had confidentially filed for an IPO in May, aiming to raise up to $2.2 billion. Despite this setback, Oura has reported significant growth, achieving profitability and a revenue of $907.9 million in its fiscal year 2025, with expectations of a 90% year-over-year revenue increase for fiscal 2026. Currently, Oura boasts 5.7 million paid members, indicating a strong customer base. CEO Tom Hale emphasized the company's commitment to delivering a successful IPO for its employees and investors, stating, "We have the luxury of choosing our moment." This strategic pause allows Oura to focus on executing its growth opportunities while awaiting a more favorable market environment. The company has already filed a registration statement with the Securities and Exchange Commission (SEC) regarding the proposed offering, although it has not yet been approved. Oura's decision to delay the IPO comes after raising over $900 million in funding last year, which significantly boosted its valuation to approximately $11 billion. The funds are intended to enhance the development of health features within its products, aligning with the growing trend of health-focused technology. As Oura navigates this period of uncertainty, stakeholders will be watching closely to see how the company capitalizes on its market position and prepares for its eventual public offering.

Healthcare Dive · Sep 29

UnitedHealthcare Appoints Robert Hunter as New President Amid Leadership Changes

UnitedHealthcare has appointed Robert Hunter as its new president, a role he will assume following 15 years with the company, where he has held various positions, including CEO of government programs. Hunter's appointment is part of a broader leadership reshuffle at the largest insurer in the U.S., which is currently focused on a modernization agenda aimed at enhancing the digital experience for patients. This initiative is crucial as the company seeks to navigate increasing scrutiny from consumers and lawmakers, amidst declining public trust in health insurers. The leadership changes come at a time when UnitedHealthcare is implementing a multi-year margin recovery plan to improve profitability in its Medicare Advantage (MA) plans. The company has faced challenges due to higher-than-expected care utilization among seniors and federal reimbursement pressures, leading to a strategic exit from certain markets and benefit reductions. Despite these challenges, UnitedHealthcare anticipates a reduction of up to 1.1 million MA members this year, which could lead to lower costs for the remaining members and improved profit margins. Tim Noel continues as CEO of UnitedHealthcare, overseeing these transitions. The company has also recently appointed Jodee Kozlak as its first chief administrative officer and promoted Dan Kueter to chief commercial officer. These changes reflect UnitedHealthcare's commitment to adapt and thrive in a competitive healthcare landscape, with expectations of being well-positioned for the upcoming year, according to CFO Wayne DeVeydt.

Healthcare Dive · Sep 29

AI Billing Tools Spark Debate Over Rising Healthcare Costs and Coding Practices

The healthcare industry is grappling with the implications of AI-backed billing tools, which insurers claim are contributing to rising healthcare costs. The Blue Cross Blue Shield Association (BCBSA) reported an increase of approximately $942 million in spending over two years, attributing this rise to the use of autonomous medical coding and AI-assisted documentation. Insurers argue that the increase in billing complexity does not correlate with a rise in patient treatment, suggesting that AI may be identifying more billable conditions rather than reflecting a sicker patient population. This has raised concerns about potential upcoding practices, where inflated diagnostic codes are submitted for higher reimbursements. In contrast, companies developing these AI technologies defend their role, stating that they are simply helping providers capture the full scope of care delivered under existing reimbursement rules. Experts from the industry emphasize that the fee-for-service model incentivizes higher billing for more procedures, which can lead to increased costs. They argue that AI tools are essential for accurately reflecting clinical realities, which can ultimately benefit patient care and resource allocation. Despite the current challenges, there is a growing shift towards value-based care models that focus on patient outcomes rather than service volume. This transition could alleviate some of the cost pressures associated with AI billing tools, as it would change the incentives for both providers and payers. As the healthcare landscape evolves, stakeholders are encouraged to engage in discussions about systemic changes that could optimize the use of AI in billing while ensuring fair reimbursement practices. The future of healthcare billing may hinge on balancing the benefits of AI with the need for cost control and accurate coding practices.

Healthcare Dive · Sep 28

Adapting Outpatient Facilities for Higher-Acuity Care: Challenges and Strategies

The transition of higher-acuity procedures from hospitals to outpatient settings presents significant challenges for healthcare owners, particularly as many existing outpatient facilities were not designed to accommodate such complex care. A recent example is a hospital-based outpatient complex in Sacramento, which opened in July 2025 and features advanced capabilities akin to a hospital, including 14 operating rooms and extensive recovery facilities. This shift is driven by rising patient acuity, clinical advancements, and evolving reimbursement policies, necessitating a reevaluation of how outpatient facilities are planned and constructed. As outpatient care evolves, facilities are increasingly required to support advanced imaging, robotics, hybrid procedures, and other complex services. Medicare's expanding policies on procedures performed outside inpatient settings further complicate construction, as traditional medical offices may lack the necessary infrastructure, such as adequate floor-to-floor height and electrical capacity. Early involvement of healthcare builders is crucial to address these challenges, allowing for better alignment of clinical programs with capital plans and identifying long-lead equipment and utility constraints. Collaboration among builders, owners, and designers is essential to create adaptable facilities that can respond to shifting clinical demands. This includes evaluating patient and staff circulation, equipment delivery routes, and opportunities for prefabrication. The focus is not only on constructing a building but also on ensuring it performs effectively from the outset of patient care. Ultimately, the most successful outpatient facilities will be those that prioritize adaptability, allowing for future expansions and changes in clinical models. For healthcare owners, this means considering structural capacity and utility services as long-term assets, while builders must engage early in the process to provide comprehensive insights beyond mere construction execution.

Healthcare Dive · Sep 28

340B Hospitals Under Scrutiny for Lower Charity Care Spending Compared to Non-340B Peers

A recent report from the Pioneer Institute and CancerCare highlights that hospitals participating in the 340B drug discount program allocate a smaller percentage of their operating expenses to charity care compared to their non-340B counterparts. Specifically, 340B hospitals spent 2.16% of their operating expenses on charity care, while non-340B hospitals spent 2.82%. This discrepancy raises concerns about the effectiveness of the 340B program, which was established to support safety-net providers caring for low-income and uninsured patients by allowing them to purchase outpatient drugs at significant discounts, often between 25% and 50%. The report emphasizes that while 340B hospitals are not legally obligated to reinvest their savings into charity care, there is an implicit expectation that these funds should benefit vulnerable populations. In fact, the analysis revealed that spending on charity care for uninsured patients was also lower at 340B hospitals, at 1.6% of operating expenses compared to 2.26% at non-340B hospitals. Critics argue that the financial benefits of the 340B program should align more closely with the needs of these patients. In response, the American Hospital Association (AHA) defended 340B hospitals, asserting that they provide substantial community benefits beyond charity care, including support for behavioral health clinics and access to essential services. The AHA claims that 340B hospitals have contributed nearly $100 billion in total community benefits, indicating a broader commitment to patient care. As scrutiny of the 340B program intensifies, lawmakers are considering reforms, including proposals to change how discounts are structured and to enforce stricter eligibility requirements for patients. The Department of Health and Human Services (HHS) has also suggested potential changes to Medicare payment rates for the program. The ongoing debate underscores the need for greater transparency and accountability in how 340B savings are utilized to support vulnerable populations.

Healthcare Dive · Sep 25

Healthcare Sector Faces Surge in Social-Engineering Attacks Amid Cybercrime Threats

Recent reports indicate a significant increase in social-engineering attacks targeting the healthcare and pharmaceutical sectors. Cybersecurity experts have identified that high-profile cybercrime groups, including ShinyHunters, are employing voice-phishing tactics to deceive healthcare workers into revealing their credentials. The Health Information Sharing and Analysis Center (Health-ISAC) has highlighted that over a dozen member organizations have fallen victim to these aggressive tactics in recent months, with attackers using medical-themed impersonation domains to enhance their deception. Errol Weiss, chief security officer at Health-ISAC, noted that the attackers are particularly aggressive, often convincing employees to click on links for password or multi-factor authentication resets. Additionally, researchers from Palo Alto Networks' Unit 42 have linked a domain, my-passkeys[.]com, to an underground cybercrime network, suggesting it is being used for phishing attacks against healthcare organizations. This domain was first identified in mid-September, indicating a sustained effort to compromise healthcare entities. The impact of these attacks is already evident, with several healthcare organizations reporting breaches. Clover Health disclosed an attack in July that compromised three employee accounts, while AdaptHealth reported a breach affecting over 4.1 million patients due to unauthorized access to cloud-based applications. Hims & Hers also faced a social-engineering attack that compromised customer data, although sensitive information remained secure. As these threats continue to evolve, healthcare organizations must bolster their cybersecurity measures to protect sensitive patient information and maintain trust in their services.

Healthcare Dive · Sep 25

FDA Nominee Heidi Overton Addresses Vaccine and Mifepristone Concerns at Senate Hearing

Heidi Overton, nominated by President Trump to lead the FDA, faced scrutiny during her Senate confirmation hearing regarding her stance on vaccines and the abortion drug mifepristone. Overton assured lawmakers that she would adhere to FDA standards and follow the law in her decision-making, particularly in light of recent political pressures surrounding vaccine policies and reproductive health. The hearing highlighted the ongoing tensions between public health guidelines and political influences, especially concerning the safety and efficacy of vaccines like the MMR shot, which has been a contentious topic under the previous FDA leadership. During the hearing, Overton affirmed the safety of the MMR vaccine, countering concerns raised by Trump and others, and emphasized her commitment to uphold FDA regulations. Lawmakers, including Senator Bill Cassidy, pressed her on the implications of political influence on vaccine safety assessments, referencing past experiences with former Health Secretary Robert F. Kennedy Jr. Overton's responses aimed to reassure the committee of her dedication to public health standards amidst a backdrop of political controversy. Additionally, Overton addressed the ongoing review of mifepristone, which has been authorized for use via telehealth. Despite her previous characterization of the drug as 'dangerous' while at a conservative think tank, she acknowledged the FDA's determination of its safety and effectiveness. This aspect of her testimony reflects the broader debate on reproductive health policies and the potential impact of political pressures on FDA operations. Looking ahead, Overton expressed intentions to enhance U.S. leadership in drug innovation, particularly in response to the competitive landscape posed by China's biotechnology sector. Her commitment to initiatives like 'Operation Trialblazer' aims to streamline drug development processes and foster a more robust domestic biotech industry. The outcome of her nomination remains uncertain, with potential implications for FDA policies and practices depending on the timing of the Senate vote, which may coincide with the upcoming midterm elections.

Healthcare Dive · Sep 24

AI's Short-Term Impact on Healthcare Costs: A Warning from CMS Administrator Dr. Mehmet Oz

During a recent address at Oracle's health summit, CMS Administrator Dr. Mehmet Oz highlighted the immediate inflationary effects of artificial intelligence (AI) on healthcare costs. He indicated that while AI is expected to enhance billing efficiency, it will initially drive up expenses before yielding long-term savings. This perspective aligns with growing concerns in the healthcare industry regarding the rising costs associated with AI-driven coding and billing practices. A study by the Blue Cross Blue Shield Association revealed that AI's influence in billing has contributed nearly $1 billion in additional healthcare costs from 2023 to 2025, raising alarms about its potential to exacerbate spending issues. Dr. Oz emphasized that the integration of AI into healthcare is crucial, stating that neglecting its use could result in lost lives in the ongoing battle against diseases. He expressed optimism that AI could eventually lower costs, particularly through the implementation of accountable care organizations (ACOs). ACOs aim to shift the focus from fee-for-service models to outcome-based care, which could incentivize providers to leverage AI for clinical efficiency rather than merely increasing billing. Despite the potential benefits, critics of the ACO model warn of financial risks for providers who may struggle to balance cost reduction with quality care. The CMS has initiated several programs to enhance ACO participation, claiming significant savings for Medicare. As the healthcare sector continues to adopt AI technologies, the challenge remains to manage the short-term cost increases while striving for long-term efficiencies and improved patient outcomes.

Healthcare Dive · Sep 24

MedPAC Chair Defends Medicare Advantage Overpayment Estimates Amid Industry Pushback

Dr. Amol Navathe, chair of the Medicare Payment Advisory Commission (MedPAC), recently defended the commission's estimates regarding Medicare Advantage (MA) overpayments during an event hosted by the Better Medicare Alliance in Washington, D.C. MedPAC's analysis indicates that the U.S. government will spend 14% more, or an additional $76 billion, on seniors enrolled in MA compared to those in traditional Medicare this year. Navathe emphasized that the commission's intent is not to undermine MA but to foster competition and generate reliable research that can inform potential reforms. The MA industry has reacted strongly against MedPAC's findings, arguing that the estimates are flawed and misrepresent the costs associated with MA plans. Insurers prefer a recent analysis from the Centers for Medicare & Medicaid Services (CMS) that suggests a significantly lower figure for overpayments. In response, the Better Medicare Alliance has launched advocacy campaigns to promote alternative research that supports the cost-effectiveness of MA plans. As Congress considers reforms to the MA program, including measures to address perceived overpayments, the debate over MedPAC's methodology has intensified. A recent bill advanced by House Republicans proposes that MedPAC conduct dual analyses of MA spending, one accounting for favorable selection—where MA beneficiaries are healthier than expected—and one that does not. This could potentially provide the MA industry with a more favorable narrative regarding costs. Navathe, who has a background in both MA plans and health policy, reiterated MedPAC's commitment to transparency and open dialogue with stakeholders. He acknowledged the importance of refining methodologies and welcomed critiques from the industry, indicating a willingness to engage in constructive discussions to improve the commission's work.

Healthcare Dive · Sep 23

Texas Hospitals File Lawsuit Against Independence Blue Cross Over $345K in Denied Claims

Five hospitals affiliated with HCA Healthcare in Texas have initiated legal action against Independence Blue Cross (IBX), claiming the insurer wrongfully denied or underpaid over $345,000 in claims for medically necessary services provided to eight patients between 2022 and 2024. The hospitals allege that IBX's denials were based on insufficient authorization, lack of medical necessity, and coding discrepancies, even for emergency services. This lawsuit highlights ongoing tensions surrounding the BlueCard program, which allows Blue Cross Blue Shield (BCBS) members to access in-network services outside their home plan's area. The BlueCard program has faced criticism for creating barriers between providers and payers, as it has been linked to reduced reimbursement rates and increased claim denials. A national class action lawsuit against BCBS previously argued that the program stifles price competition by enforcing uniform reimbursement rates across state lines, leading to financial strain on hospitals that treat traveling patients. Despite a recent $2.8 billion settlement aimed at improving transparency and efficiency within the BlueCard program, many providers, including the plaintiffs in this case, continue to face challenges with claim approvals and reimbursements. The lawsuit, filed in federal court, contends that IBX's requirement for prior authorization for emergency care violates both federal and state regulations. The hospitals assert that IBX failed to provide adequate clinical justification for its adverse decisions and neglected to conduct thorough medical necessity reviews for appeals. The plaintiffs, which include HCA Houston Healthcare North Cypress, HCA Houston Healthcare Medical Center, The Woman’s Hospital of Texas, Methodist Healthcare System of San Antonio, and St. David’s Medical Center, are seeking reimbursement for the denied claims. IBX has refrained from commenting on the ongoing litigation.

Healthcare Dive · Sep 22

Lawsuit Challenges Medicaid Work Requirements for Medically Frail Individuals

A new lawsuit has been filed against the Centers for Medicare & Medicaid Services (CMS) regarding the upcoming Medicaid work requirements, which are set to take effect in 2027. The lawsuit argues that the current guidelines do not adequately exempt medically frail individuals, potentially leading to millions losing their health insurance. Filed on behalf of five Medicaid enrollees and various provider groups, the suit claims that the CMS's interim final rule imposes excessive burdens on beneficiaries to prove their medical frailty, which is necessary to qualify for exemptions from the mandated 80 hours of work, education, or volunteer activities. The One Big Beautiful Bill Act, enacted last year, introduced significant cuts to Medicaid and established the first work requirements for the program. While the law initially provided broad exemptions for those deemed medically frail, the recent guidance from CMS has narrowed this definition, requiring individuals to regularly demonstrate their frailty through provider assessments. This has raised concerns among healthcare professionals, who argue that such requirements could jeopardize patient coverage and health outcomes. Key stakeholders, including the American College of Physicians and the American Academy of Pediatrics, have voiced their opposition, stating that the new rules overstep the traditional patient-provider relationship. They contend that physicians should focus on diagnosing and treating medical conditions rather than assessing patients' work capabilities. The lawsuit also highlights the problematic 12-month lookback period for claims data, which could exclude many eligible individuals from receiving exemptions. As the legal battle unfolds, the implications for Medicaid enrollees and healthcare providers remain significant. If the lawsuit succeeds, it could lead to a reevaluation of the CMS's approach to medical frailty exemptions, potentially safeguarding coverage for vulnerable populations. However, similar challenges have previously been dismissed in court, raising questions about the future of these regulations and their impact on healthcare access.

Healthcare Dive · Sep 22

Colorado Court Rules Doctor's Burnout Does Not Constitute Disability Under ADA

In a recent ruling, a Colorado federal judge determined that burnout experienced by a former oncologist does not qualify as a disability under the Americans with Disabilities Act (ADA). The case, Peddada v. Catholic Health Initiatives Colorado, concluded on September 16, 2026, when the judge sided with the health system against the oncologist's claims of disability discrimination following his termination. The court found that the plaintiff's burnout did not substantially impair any major life activities, which is a key requirement for a condition to be classified as a disability under federal law. The judge's decision highlighted that while the ADA Amendments Act of 2008 aimed to broaden the definition of disability, not every impairment meets the criteria. The plaintiff had argued that his burnout affected his ability to sleep, think, concentrate, and communicate. However, the court relied on expert testimony and clinical evaluations that indicated no significant impairment in these areas outside of his job performance. This ruling underscores the challenges faced by healthcare professionals in proving that burnout or similar conditions qualify as disabilities under current legal standards. This case is part of a broader trend in which courts have been cautious in interpreting what constitutes a disability. Previous rulings have similarly denied claims based on conditions like heart disease and job-related stress, emphasizing that the impairment must limit major life activities significantly. The implications of this ruling may affect how healthcare professionals approach burnout and seek accommodations, as well as how employers respond to such claims in the future.

Healthcare Dive · Sep 21

Trump's MFN Drug Deals May Complicate Medicare Savings Efforts

President Donald Trump's most-favored nation (MFN) agreements with 26 pharmaceutical companies aim to lower drug prices and reduce federal spending. However, a recent study from Mass General Brigham indicates that these deals could potentially decrease projected Medicare savings by nearly 80%. The MFN agreements, which include commitments from nine mid-sized firms to offer state Medicaid programs drug prices aligned with those in other developed nations, may inadvertently undermine other cost-reduction strategies for Medicare. The proposed Medicare models, GLOBE and GUARD, are designed to peg U.S. drug prices to those in similar countries, potentially saving Medicare an estimated $11.6 billion annually. However, some drugmakers believe their MFN agreements may exempt them from these models, which could significantly diminish the anticipated savings. The complexity of the healthcare system, with its intricate web of agreements among manufacturers, insurers, and pharmacy benefit managers, complicates the direct correlation between manufacturer discounts and patient savings. While direct-to-consumer discounts through platforms like TrumpRx may offer some savings, the overall impact of the MFN deals on drug spending remains uncertain. Analysts suggest that the financial implications for drug companies may be minimal, and it is unclear whether these agreements will lead to substantial savings for consumers or federal programs. As the proposed Medicare models are set to launch in the coming years, the potential legal challenges and the evolving landscape of drug pricing will be critical to monitor.

Healthcare Dive · Sep 21

AI Innovations Address Clinical Data Abstraction Bottleneck in Biomedical Research

Clinical data abstraction has long been a significant bottleneck in biomedical research, hindering the ability to leverage vast amounts of clinical data for scientific insights. A recent pilot project led by Verily Health, in collaboration with UCHealth, the University of Colorado Anschutz, and RefinedScience, aimed to evaluate the effectiveness of AI in transforming unstructured clinical data into structured, research-ready variables. This initiative is crucial as healthcare organizations are inundated with fragmented data, including physician notes and genomic reports, which are essential for understanding patient journeys but challenging to analyze. The pilot focused on acute myeloid leukemia (AML), a complex condition characterized by heterogeneous patient populations and intricate genomic information. By employing a healthcare-native AI approach, the project successfully improved the accuracy of clinical data extraction from an initial 72% to over 95%. This was achieved by integrating clinical knowledge into the AI's processing framework, allowing it to make medically plausible distinctions and reducing the reliance on manual data abstraction from 1,200 hours to just 40 hours. The implications of this pilot extend beyond mere efficiency gains; they redefine the role of researchers, enabling them to focus on uncovering high-value insights rather than managing fragmented data. The success of this project highlights the potential of AI to accelerate scientific discovery and advance precision medicine, particularly in identifying new biomarkers and therapeutic opportunities. As AI technologies continue to evolve, they promise to unlock the latent value within clinical datasets, ultimately enhancing patient care and treatment outcomes.

Healthcare Dive · Sep 21

Ascension Divests Arizona Medicaid Plan Mercy Care to Aetna Amid Strategic Portfolio Restructuring

Ascension has announced the sale of its ownership stake in Mercy Care, a Medicaid insurer in Arizona, to Aetna, a subsidiary of CVS Health. This move is part of Ascension's ongoing strategy to streamline its operations and mitigate insurance risk following a series of financial challenges, including a significant cyberattack in 2024. Mercy Care, which serves approximately 404,000 members, has been co-owned by Ascension and Dignity Health since its inception in 1985, although Aetna has managed its operations since 2002. The financial terms of the deal have not been disclosed, and the transaction is pending regulatory approval. Ascension's decision to divest from Mercy Care aligns with its recent trend of selling off various assets, including hospitals and insurance stakes, to focus on outpatient care and improve its financial standing. The health system reported a net income of $1.5 billion for the 2026 fiscal year, a significant increase from $918 million the previous year. Mercy Care has proven to be a profitable entity, generating $34 million in income last year. However, the broader trend among healthcare providers indicates a growing reluctance to maintain insurance operations due to rising medical costs and regulatory uncertainties. This year has seen several integrated healthcare providers, including Providence and Baylor Scott & White, exit the insurance market. Aetna's acquisition of Mercy Care is strategic, as the insurer has extensive experience managing the plan and its members, which minimizes the risks typically associated with such purchases. The dual special needs plan structure of Mercy Care, which caters to beneficiaries enrolled in both Medicare and Medicaid, makes it an attractive asset due to its higher profitability compared to standard Medicare Advantage plans. Aetna has been focusing on expanding its dual special needs offerings, indicating that this acquisition aligns with its long-term business strategy.

Healthcare Dive · Sep 18

One-Third of Insured U.S. Adults Face Medical Debt, Commonwealth Fund Reports

A recent survey by the Commonwealth Fund reveals that one-third of U.S. adults with private insurance are struggling with medical debt, challenging the notion that insurance provides adequate financial protection against healthcare costs. The survey, which included over 6,300 working-age adults, found that 37% of those with medical debt have depleted their savings to cover bills, while 30% have postponed necessary medical care. Additionally, 30% reported cutting back on essential expenses such as food and housing to manage their financial burdens. The findings highlight a significant issue within the U.S. healthcare system, where even insured individuals are not shielded from the financial repercussions of medical care. Nearly half of those with medical debt owe $2,000 or more, representing about 15% of all privately insured adults aged 19 to 64. Hospital care emerged as the primary contributor to this debt, with two-thirds of respondents attributing their financial struggles to hospital services. Other sources of debt included doctor’s offices, lab work, and dental care. The Commonwealth Fund's report emphasizes the need for policy reforms to address the growing medical debt crisis. Suggested measures include banning medical debt from credit reports, eliminating deductibles in commercial insurance plans, and capping provider payment rates. While uninsured adults still face the highest levels of medical debt, the survey underscores that insured individuals are also significantly affected, with many attributing their debt to their insurance providers and the healthcare system as a whole. As healthcare costs continue to rise and more Americans risk losing insurance coverage due to policy changes, the Commonwealth Fund calls for a reevaluation of healthcare policies to move towards universal coverage. The report serves as a critical reminder of the financial vulnerabilities faced by many Americans, regardless of their insurance status.

Healthcare Dive · Sep 18

Study Reveals Broadband Access Hinders Telehealth Adoption for 12 Million Americans

A recent study published in JAMA Health Forum highlights that nearly 12 million Americans lack adequate broadband access to utilize telehealth services effectively. The research, conducted by the University of Vermont, indicates that the majority of those affected reside in rural areas, where insufficient infrastructure and high subscription costs create significant barriers to accessing virtual healthcare. This issue is particularly pressing as telehealth has the potential to enhance healthcare access for underserved populations, especially in remote regions. The study analyzed data from 41 states, revealing that 11.9 million individuals live in 'broadband deserts' where internet speeds fall below the Federal Communications Commission's minimum threshold of 100/20 megabits per second. Alarmingly, 88% of these individuals are situated in rural areas, which already face challenges such as limited ambulance availability and other healthcare services. The researchers emphasized that persistent broadband disparities, particularly in the South and West, exacerbate the difficulties in obtaining timely medical care. Despite 95% of rural residents having access to computing devices and nearly 89% holding broadband subscriptions, the study found that poor connection quality still hampers telehealth engagement. The researchers pointed out that while broadband access is essential for telehealth, it does not guarantee its use, as socioeconomic factors, healthcare practitioner availability, and behavioral barriers also play significant roles. The surge in telehealth usage during the COVID-19 pandemic has not fully translated into sustained adoption, with ongoing technology gaps and inconsistent reimbursement policies posing challenges. To address these issues, the researchers advocate for increased investment in broadband infrastructure and the expansion of reimbursement policies to facilitate broader telehealth access.

Healthcare Dive · Sep 18

CVS Aetna Unifies Cancer Care Prior Authorizations to Enhance Patient Experience

CVS Health's Aetna division has announced a significant reform in its prior authorization process for cancer care, consolidating various preapproval requirements into a single unified request. This change aims to alleviate one of the major pain points for patients and healthcare providers in the U.S. Aetna, which serves 26 million members, will bundle prior authorizations for cancer treatments, including chemotherapy, immunotherapy, and radiation oncology services, along with necessary imaging procedures like MRIs and CAT scans. The new system will be available to Medicaid members in select states starting September 2, with plans for a broader rollout across other insurance lines in 2024. The move comes as insurers face increasing pressure to streamline prior authorization processes, which have been criticized for contributing to provider burnout and delaying patient care. Aetna's initiative builds on a successful pilot program that combined authorizations for lung, breast, and prostate cancer, with nearly 25% of eligible members already benefiting from the bundled approach. By reducing the average number of prior authorizations from four to one for cancer patients, Aetna aims to minimize administrative burdens on healthcare providers and expedite treatment. Katerina Guerraz, Aetna's COO and Medicaid president, emphasized the importance of focusing on patient care rather than paperwork, stating that the new bundles will help remove barriers that can delay necessary treatments. The initial rollout will affect Medicaid members in states such as Oklahoma, Illinois, and Florida, with plans to extend the bundles to Medicare and commercial members by mid-2027. Despite these advancements, skepticism remains among healthcare providers regarding insurers' commitments to reducing administrative hurdles, particularly given that a significant portion of prior authorization denials are overturned upon appeal. Recent data indicates that insurers denied approximately 12.5% of standard prior authorization requests in government programs last year, highlighting ongoing challenges in the prior authorization landscape.

Healthcare Dive · Sep 17

AI's Impact on Pharmaceutical Sales Representatives: Five Transformative Changes Ahead

The pharmaceutical industry is on the brink of a significant transformation as artificial intelligence (AI) begins to reshape the role of sales representatives. Over the past 15 years, industry experts have noted a growing interest in how AI can enhance the efficiency and effectiveness of pharma reps. This shift is crucial as companies seek to adapt to changing market dynamics and the increasing demand for personalized healthcare solutions. AI technologies are expected to streamline processes, improve customer engagement, and provide valuable insights into physician preferences and patient needs. One of the key areas where AI will make a difference is in data analysis. Sales representatives will have access to advanced analytics that can help them understand market trends and identify potential opportunities more effectively. This data-driven approach will enable reps to tailor their pitches and focus on the most relevant products for healthcare providers. Additionally, AI can assist in automating routine tasks, allowing reps to spend more time building relationships with healthcare professionals. Moreover, AI-driven tools can enhance training and development for sales teams, providing them with real-time feedback and personalized learning experiences. This will not only improve their product knowledge but also their ability to engage with clients in a meaningful way. As the industry continues to evolve, the integration of AI into pharmaceutical sales strategies will be essential for maintaining competitive advantage. As we look to the future, it is clear that the role of pharmaceutical sales representatives will be redefined by AI technologies. Companies that embrace these changes will likely see improved sales performance and stronger relationships with healthcare providers. The ongoing evolution of AI in this sector will be closely monitored by industry stakeholders, as its implications for sales strategies and healthcare delivery are profound.

The Medical Futurist · Sep 17

Survey Reveals 70% of Gen Z Healthcare Workers Plan to Leave Jobs Within a Year

A recent survey conducted by Harris Poll indicates that nearly 70% of Gen Z healthcare workers in the U.S. are considering leaving their current positions within the next year. This alarming trend emerges as the healthcare industry grapples with an impending workforce shortage, projected to reach a deficit of approximately 500,000 workers by 2038. The survey, which included over 1,500 healthcare employees, highlights a significant disconnect between Gen Z workers and their employers, with less than half expressing loyalty to their current jobs. The findings reveal that while 59% of all healthcare workers are contemplating a job change, the sentiment is particularly pronounced among Gen Z, who cite a lack of professional development and career advancement opportunities as primary reasons for their dissatisfaction. Only 25% of Gen Z respondents believe their employers are invested in their long-term career growth, despite 86% indicating that access to education and training would enhance their career prospects. Employers are aware of the challenges, with 47% acknowledging that inadequate career training contributes to employee turnover. However, only 48% have implemented formal workforce education strategies. As older healthcare professionals approach retirement, the need for effective recruitment and retention strategies for younger workers becomes critical. Experts suggest that organizations must clearly communicate career advancement pathways and provide educational benefits to attract and retain Gen Z talent. To address these issues, healthcare employers are encouraged to engage directly with employees about their benefits and career development opportunities, moving beyond traditional communication methods. This shift could be essential not only for filling the gaps left by retiring workers but also for adapting to the evolving expectations of a new generation entering the workforce.

Healthcare Dive · Sep 16

CMS Expands ACCESS Model to Include More Chronic Conditions in 2027

The Centers for Medicare & Medicaid Services (CMS) is set to enhance its ACCESS model by adding four new chronic conditions starting in spring 2027. This expansion will increase the number of conditions covered under the outcomes-based payment model from four to eight, now including heart failure, chronic obstructive pulmonary disease (COPD), substance use disorders, and tobacco cessation. Additionally, the payment period for conditions related to bone, joint, and mobility issues causing chronic pain will be extended. Launched on July 5, 2026, the ACCESS model initially focused on hypertension, diabetes, chronic musculoskeletal pain, and depression. It aims to incentivize healthcare providers to utilize health technologies for managing chronic conditions, aligning with HHS Secretary Robert F. Kennedy Jr.'s objective of reducing chronic disease prevalence in the U.S. However, full payment to participating organizations is contingent upon achieving specific health outcomes for Medicare enrollees, such as improvements in blood pressure or lipid levels. From July 5, 2026, to December 31, 2027, participants can expect payments ranging from $180 to $420 for the first year of patient care, with follow-on payments between $90 and $210. Despite some digital health companies expressing concerns about the sustainability of these payment rates, over 150 healthcare providers and digital health firms, including Verily and Whoop, have already joined the model. CMS Administrator Dr. Mehmet Oz emphasized the potential broader impact of the ACCESS model, suggesting it could influence payment structures in Medicare Advantage, the Department of Veterans Affairs, Medicaid, and TRICARE, thereby promoting a shift towards outcome-based care across various healthcare systems.

Healthcare Dive · Sep 16

New Arbiter Certified Amid Surge in Surprise Billing Disputes Under No Surprises Act

The U.S. Department of Health and Human Services (HHS) has certified Physio Solutions, operating as Medlitix, as the 17th arbiter in the independent dispute resolution (IDR) process established by the No Surprises Act. This certification comes as the volume of disputes between healthcare providers and insurers has surged, with 1.4 million disputes filed in the latter half of 2025 alone, marking a 16% increase from the first half of the year. The No Surprises Act, which took effect in 2022, aims to protect patients from unexpected out-of-network medical bills by providing a structured arbitration process for payment disputes. The addition of Medlitix is part of a broader effort by the Centers for Medicare & Medicaid Services (CMS) to address the backlog of cases in the IDR process, which has exceeded government expectations. Since June 2025, four new arbiters have been added to the system, increasing the total from 13 to 17. However, despite being certified, Medlitix is not yet accepting new disputes, and there is no timeline available for when they will begin operations. The IDR process has faced scrutiny from lawmakers, including Rep. Frank Pallone, who is investigating the decision-making practices of arbiters amid concerns that the system is not functioning as intended. A recent report from Georgetown University highlighted potential biases in arbiter decisions, suggesting that providers may choose arbiters who favor their claims, which could lead to inflated payouts. Payers have also criticized the IDR process for allowing ineligible disputes, contributing to the overwhelming number of claims and inappropriate reimbursements for providers. As the situation evolves, stakeholders are closely monitoring the effectiveness and integrity of the IDR process.

Healthcare Dive · Sep 15

Study Predicts Up to 2.3M Young Adults May Lose Medicaid Due to New Work Requirements

A recent analysis by the Urban Institute indicates that up to 2.3 million young adults could lose their Medicaid coverage by 2028 due to new work requirements and increased eligibility checks mandated by the 'Big Beautiful Bill.' This legislation, signed into law by President Trump, aims to reduce Medicaid spending by nearly $1 trillion over the next decade, impacting over 66 million low-income individuals nationwide. The report highlights that while nearly 90% of young adults aged 19 to 24 currently meet the new work requirements or qualify for exemptions, the lack of reliable state data to verify this information poses significant barriers to maintaining their coverage. The analysis outlines three potential scenarios for young adult Medicaid enrollment: a high-mitigation scenario, where states implement policies that help retain coverage; a medium-mitigation scenario; and a low-mitigation scenario, which could see enrollment drop by as much as 48%. The report estimates that between 1.1 million and 2.3 million young adults could be affected, with those in gig work or frequently changing residences facing the highest risk of disenrollment. Key factors influencing these outcomes include state-level decisions on how to implement the new policies, including the definition of exemptions and the documentation required to prove eligibility. While some states are adopting more flexible verification processes, others are enforcing stricter requirements, complicating the situation for young adults who may lack awareness of Medicaid's administrative complexities. The Urban Institute emphasizes that the extent of coverage loss will largely depend on states' data matching capabilities and their implementation choices, making it crucial for stakeholders to monitor these developments closely.

Healthcare Dive · Sep 15

Addressing Hidden Costs of Manual Work in Ambulatory Care: A Call for Automation

Ambulatory care practices often overlook the hidden costs associated with manual work, which can significantly impact operational efficiency and patient care. While leaders are aware of direct expenses like salaries and technology, the time spent on redundant tasks—such as entering the same information multiple times or making follow-up calls—can accumulate to substantial inefficiencies. For instance, a recent survey by the American Medical Association revealed that physicians and their staff dedicate an average of 13 hours weekly to prior authorizations, with 40% of physicians employing staff solely for this purpose. The inefficiencies of manual processes not only lead to wasted time but also create a cycle of rework. Incomplete or incorrectly entered information necessitates additional communication and follow-ups, further straining resources and affecting staff productivity. This cycle can lead to delays in patient care, as patients often find themselves repeating information or waiting longer for responses. The intertwined nature of operational, workforce, and patient experience challenges highlights the need for a comprehensive approach to address these issues. To mitigate these hidden costs, practices should focus on automation not as a means to replace staff but to enhance their capacity. By automating routine tasks, practices can streamline workflows, reduce unnecessary touches, and ultimately improve both staff efficiency and patient satisfaction. Identifying areas where time is lost—such as repetitive information requests or tasks that generate callbacks—can guide practices in implementing effective automation strategies. As practices begin to automate, it is crucial to measure the impact on workflow efficiency and staff workload. Initial gains may appear modest, but over time, these improvements can lead to significant enhancements in operational performance and patient care. By addressing the hidden costs of manual work, ambulatory care practices can better allocate their resources and focus on delivering high-quality care.

Healthcare Dive · Sep 14